714
Participants
Start Date
February 28, 2006
Primary Completion Date
November 30, 2007
Study Completion Date
August 31, 2008
placebo
1 mg placebo twice daily by mouth for 12 weeks
Varenicline
1 mg twice daily by mouth for 12 weeks
Pfizer Investigational Site, Tau-Yuan Hsien
Pfizer Investigational Site, Capital Federal
Pfizer Investigational Site, Ciudad de Buenos Aires
Pfizer Investigational Site, Concord
Pfizer Investigational Site, Herston
Pfizer Investigational Site, Berlin
Pfizer Investigational Site, Taipei
Pfizer Investigational Site, Athens
Pfizer Investigational Site, Marseille
Pfizer Investigational Site, Caen
Pfizer Investigational Site, Tlalpan
Pfizer Investigational Site, Pireaus
Pfizer Investigational Site, Toulouse
Pfizer Investigational Site, Göttingen
Pfizer Investigational Site, Madison
Pfizer Investigational Site, Tübingen
Pfizer Investigational Site, Hartford
Pfizer Investigational Site, Boston
Pfizer Investigational Site, Porto Alegre
Pfizer Investigational Site, São Paulo
Pfizer Investigational Site, London
Pfizer Investigational Site, Ottawa
Pfizer Investigational Site, Drummondville
Pfizer Investigational Site, Québec
Pfizer Investigational Site, Brno
Pfizer Investigational Site, Prague
Pfizer Investigational Site, Aarhus C
Pfizer Investigational Site, Hellerup
Pfizer Investigational Site, Monterrey
Pfizer Investigational Site, Amsterdam
Pfizer Investigational Site, Zuthpen
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Carshalton
Pfizer Investigational Site, Bradford
Pfizer Investigational Site, Leicester
Pfizer Investigational Site, Paisley
Lead Sponsor
Pfizer
INDUSTRY